XML 131 R103.htm IDEA: XBRL DOCUMENT v3.23.1
Additional Financial Information of Parent Company, Financial Statements Schedule I - Condensed Statements of Cash flows (Details)
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
CNY (¥)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
CNY (¥)
Dec. 31, 2020
CNY (¥)
Cash flows from operating activities:        
Net (loss) income ¥ 976,571 $ 141,587 ¥ 1,314,131 ¥ (745,225)
Adjustments to reconcile net income to net cash provided by operating activities:        
Income from equity in affiliates, net of dividends (33,708) (4,887) (206,218) (60,397)
Share-based settlement expenses     19,908 1,290,811
Changes in operating assets and liabilities:        
Amounts due from related parties (2,040) (296) 53,194 14,990
Other current assets (17,001) (2,465) 57,135 (96,832)
Deferred tax assets (84,904) (12,310) (119,606) (67,330)
Contingent liabilities 99,000 14,354 (11,398) 530,433
Other current liabilities (178,823) (25,927) 191,420 (361,210)
Other non-current liabilities (40,260) (5,837) 99,165 (2,578)
Net cash provided by operating activities 632,901 91,764 1,521,838 796,353
Cash flows from investing activities:        
Proceeds from long-term investments 19,366 2,808 8,465 26,606
Net cash provided by (used in) investing activities 74,289 10,773 (2,572,094) 352,584
Cash flows from financing activities:        
Proceeds from issuance of ordinary shares upon exercise of stock options 247,015 35,814    
Payment for repurchase of ordinary shares     (372,376) (281,610)
Net cash (used in) provided by financing activities 233,761 33,892 (513,121) (371,422)
Effect of exchange rate changes 81,054 11,751 (46,714) (148,745)
Net increase (decrease) in cash and cash equivalents 1,022,005 148,180 (1,610,091) 628,770
Cash and cash equivalents - beginning of year 3,412,613 494,782 5,022,704 4,393,934
Cash and cash equivalents - end of year 4,434,618 642,962 3,412,613 5,022,704
Parent company        
Cash flows from operating activities:        
Net (loss) income 976,571 141,587 1,314,131 (745,225)
Adjustments to reconcile net income to net cash provided by operating activities:        
Income from equity in subsidiaries and VIEs, net of dividends (942,081) (136,586) (1,309,836) (978,658)
Income from equity in affiliates, net of dividends (41,385) (6,000) (28,606) (58,913)
Share-based settlement expenses     19,908 1,290,811
Changes in operating assets and liabilities:        
Amounts due from subsidiaries and VIEs       356,685
Amounts due from related parties (63) (9) 18 (94)
Amounts due to subsidiaries and VIEs 52,262 7,577 28,584 56,937
Other current assets     40,772 (31,417)
Deferred tax assets       1,226
Contingent liabilities     (11,398) 530,433
Other current liabilities (31,336) (4,543) 11,828 (10,249)
Other non-current liabilities     (2,276) 908
Net cash provided by operating activities 13,968 2,026 63,125 412,444
Cash flows from investing activities:        
Increase in investments in subsidiaries and VIEs (17,492) (2,536) (1,120,785) (43,690)
Capital return from investments in affiliates       101,114
Net cash provided by (used in) investing activities (17,492) (2,536) (1,120,785) 57,424
Cash flows from financing activities:        
Proceeds from issuance of ordinary shares upon exercise of stock options 1,493 216 11,114 33,372
Proceeds from advances from subsidiaries 287,876 41,738 537,604  
Repayment of advances from subsidiaries (448,387) (65,010) (82,481)  
Payment for repurchase of ordinary shares     (372,376) (281,610)
Proceeds from offering, net of issuance cost 247,015 35,814    
Net cash (used in) provided by financing activities 87,997 12,758 93,861 (248,238)
Effect of exchange rate changes 41,227 5,977 (171,897) (111,190)
Net increase (decrease) in cash and cash equivalents 125,700 18,225 (1,135,696) 110,440
Cash and cash equivalents - beginning of year 224,145 32,498 1,359,841 1,249,401
Cash and cash equivalents - end of year ¥ 349,845 $ 50,723 ¥ 224,145 ¥ 1,359,841